Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
Clinical trial NCT02481180 · TERMINATED
Trial details
- NCT number
- NCT02481180
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-31
- Primary completion
- 2017-11-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.